To determine whether SLC1A5 is a key downstream target of FTO promoting glutamine reprogramming, growth, and survival in ccRCC cells, we ectopically expressed SLC1A5 in FTO knockdown cells (Fig. 4A). This evidence concerns the gene SLC1A5 and nonpapillary renal cell carcinoma.